Ageing and Cellular Senescence
On this page
Direct answer
Why does a fibroblast in culture stop dividing after roughly fifty population doublings? That is the Hayflick limit, and replicative senescence is the cellular prototype of ageing. The counting device is the telomere: TTAGGG repeats lose 50-200 base pairs with each division because DNA polymerase cannot copy the lagging strand's end, and critically short telomeres trip a DNA-damage response through p53 and p16INK4a that halts the cycle permanently. Senescent cells do not die — they persist, metabolically active and secretory, releasing IL-6, IL-8 and matrix metalloproteinases (the senescence-associated secretory phenotype, SASP) that chronically inflame old tissue, promote fibrosis and feed neighbouring pre-malignant cells. Cancer is the mirror image: it switches on telomerase and divides forever.
What you must remember
- Numbers to quote: Hayflick limit about 50 doublings for fetal fibroblasts; telomere attrition of roughly 50-200 base pairs per division; telomerase (a reverse transcriptase, TERT with TERC RNA) constitutive in stem cells, germline and the large majority of cancers, absent from most somatic cells.
- Senescence markers for the exam: senescence-associated beta-galactosidase at pH 6, p16INK4a (CDKN2A), p21, and senescence-associated heterochromatin foci; DNA damage foci at dysfunctional telomeres (gamma-H2AX).
- Two flavours of senescence: replicative (telomere-driven) and stress-induced (oncogene activation, oxidative stress, irradiation) — the latter is a tumour-suppressor mechanism that must be counted a good thing until cells accumulate.
- SASP payload: IL-6, IL-8, MCP-1, matrix metalloproteinases and growth factors — the mechanistic bridge from senescent cells to chronic inflammation ("inflammageing"), fibrosis and a cancer-permissive microenvironment.
- Telomere biology made clinical: dyskeratosis congenita — mutations in DKC1, TERT or TERC — presents with the triad of nail dystrophy, leukoplakia and reticular skin pigmentation, then aplastic anaemia and pulmonary fibrosis: ageing biology compressed into a young patient.
- Progeria pair: Hutchinson-Gilford progeria (de novo LMNA mutation producing progerin, accelerated ageing with death in the teens of myocardial infarction or stroke) and Werner syndrome (WRN helicase, adult progeria with cataracts, diabetes, sarcomas).
- Ageing theories to list: free-radical (Harman), somatic mutation and DNA-repair decline, mitochondrial dysfunction, proteostasis failure, stem-cell exhaustion and immunosenescence with thymic involution; caloric restriction extends lifespan across species, sirtuins mediating part of the response.
- Cancer and ageing, one coin: the same checkpoints (p53, p16INK4a) enforce senescence and suppress tumours, which is why senescent cells accumulate with age as suppressed cancers-in-waiting.
The telomerase paradox
Set the two facts side by side and the paradox is stark: short telomeres drive ageing, yet telomerase — the enzyme that lengthens them — is a hallmark of cancer. Resolve it through the checkpoint machinery. In a normal cell, a critically short telomere is read as double-strand break damage: p53 fires, the cell senesces or dies, and the clone stops — tumour suppression at the price of tissue ageing. For a cell to become malignant it must first crash through these checkpoints (p53 loss, for instance), which leaves it dividing with telomeres in free fall, heading for crisis — chromosome fusion, breakage, death. The rare survivor that reactivates telomerase gains unlimited division: immortality, the sixth hallmark of cancer. So telomerase is neither good nor bad — it is the hinge. This is also why telomere-shortening syndromes (dyskeratosis congenita, some familial aplastic anaemias and pulmonary fibrosis) present as premature organ failure, and why telomerase-inhibitor strategies in oncology walked straight out of this reasoning.
High-yield viva angles
Expect the direct number — fifty doublings, Hayflick and Moorhead, 1961. Be ready to explain why neurons and cardiomyocytes age differently from gut epithelium: post-mitotic cells accumulate damage rather than divisions, so their ageing is proteostatic and mitochondrial, not telomeric. The examiner may ask whether clearing senescent cells helps: senolytic drugs improve function in animal models and are in early human trials — answer with the hedge "promising, not yet standard". And keep Werner versus Hutchinson-Gilford clean: WRN is adult-onset with cancer risk; LMNA progerin is childhood with vascular death.
Frequently asked questions
What is the Hayflick limit?
The finite number of divisions — about 50 population doublings — that normal somatic cells complete in culture before replicative senescence.
Why do telomeres shorten with each division?
DNA polymerase synthesises only 5-prime to 3-prime and cannot fill the lagging strand's terminal end, so 50-200 base pairs are lost each cycle.
What is the senescence-associated secretory phenotype?
The inflammatory cocktail (IL-6, IL-8, MMPs) that senescent cells release, driving inflammageing, fibrosis and tumour-promoting microenvironments.
Which syndrome links short telomeres to aplastic anaemia?
Dyskeratosis congenita, from DKC1, TERT or TERC mutations, with nail dystrophy, leukoplakia, pigmentation and marrow failure.
Why is telomerase a hallmark of cancer?
Reactivated telomerase stabilises telomeres, letting malignant clones divide indefinitely — the immortality step in multistep carcinogenesis.